![hqdefault.jpg](https://jnj-content-lab2.brightspotcdn.com/dims4/default/5df48bf/2147483647/strip/true/crop/480x270+0+45/resize/1440x810!/quality/90/?url=https%3A%2F%2Fi.ytimg.com%2Fvi%2FC6DLa7JLjiw%2Fhqdefault.jpg)
No more epidemics
Dr. Johan Van Hoof, Global Head of Janssen Vaccines, sat down for an on-camera interview with The Business Debate that has been posted on The Wall Street Journal. He spoke about Johnson & Johnson’s commitment to combat Ebola through Janssen’s vaccine development program, global partnerships and broader activities to promote pandemic preparedness.
- X (Twitter)
Copy link